NJ State Employees Deferred Compensation Plan’s Thermo Fisher Scientific TMO Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,000	Closed	-$2.91M	–	372
2025 Q3	$2.91M	Hold	6,000	–	–	0.32%	69
2025 Q2	$2.43M	Hold	6,000	–	–	0.29%	80
2025 Q1	$2.99M	Hold	6,000	–	–	0.38%	59
2024 Q4	$3.12M	Hold	6,000	–	–	0.38%	49
2024 Q3	$3.71M	Hold	6,000	–	–	0.44%	48
2024 Q2	$3.32M	Hold	6,000	–	–	0.41%	49
2024 Q1	$3.49M	Hold	6,000	–	–	0.44%	50
2023 Q4	$3.18M	Hold	6,000	–	–	0.44%	49
2023 Q3	$3.04M	Hold	6,000	–	–	0.46%	48
2023 Q2	$3.13M	Hold	6,000	–	–	0.45%	48
2023 Q1	$3.46M	Hold	6,000	–	–	0.53%	39
2022 Q4	$3.3M	Hold	6,000	–	–	0.53%	47
2022 Q3	$3.04M	Hold	6,000	–	–	0.52%	50
2022 Q2	$3.26M	Hold	6,000	–	–	0.53%	46
2022 Q1	$3.54M	Hold	6,000	–	–	0.48%	51
2021 Q4	$4M	Hold	6,000	–	–	0.5%	45
2021 Q3	$3.43M	Hold	6,000	–	–	0.47%	50
2021 Q2	$3.03M	Hold	6,000	–	–	0.4%	61
2021 Q1	$2.74M	Hold	6,000	–	–	0.39%	65
2020 Q4	$2.79M	Hold	6,000	–	–	0.43%	57
2020 Q3	$2.65M	Hold	6,000	–	–	0.48%	49
2020 Q2	$2.17M	Hold	6,000	–	–	0.41%	63
2020 Q1	$1.7M	Hold	6,000	–	–	0.39%	66
2019 Q4	$1.95M	Hold	6,000	–	–	0.33%	79
2019 Q3	$1.75M	Hold	6,000	–	–	0.32%	80
2019 Q2	$1.76M	Hold	6,000	–	–	0.32%	80
2019 Q1	$1.64M	Buy	6,000 +1,000	+20%	+$249K	0.3%	84
2018 Q4	$1.12M	Hold	5,000	–	–	0.23%	98
2018 Q3	$1.22M	Hold	5,000	–	–	0.21%	108
2018 Q2	$1.04M	Hold	5,000	–	–	0.19%	124
2018 Q1	$1.03M	Hold	5,000	–	–	0.18%	134
2017 Q4	$949K	Hold	5,000	–	–	0.16%	163
2017 Q3	$946K	Hold	5,000	–	–	0.17%	174
2017 Q2	$872K	Hold	5,000	–	–	0.16%	198
2017 Q1	$768K	Hold	5,000	–	–	0.15%	223
2016 Q4	$706K	Hold	5,000	–	–	0.14%	232
2016 Q3	$795K	Hold	5,000	–	–	0.16%	208
2016 Q2	$739K	Hold	5,000	–	–	0.16%	218
2016 Q1	$726K	Hold	5,000	–	–	0.15%	219
2015 Q4	$709K	Hold	5,000	–	–	0.15%	230
2015 Q3	$611K	Hold	5,000	–	–	0.13%	248
2015 Q2	$649K	Hold	5,000	–	–	0.13%	260
2015 Q1	$672K	Hold	5,000	–	–	0.13%	257
2014 Q4	$626K	Hold	5,000	–	–	0.12%	265
2014 Q3	$609K	Hold	5,000	–	–	0.12%	272
2014 Q2	$590K	Hold	5,000	–	–	0.12%	284
2014 Q1	$601K	Hold	5,000	–	–	0.12%	280
2013 Q4	$557K	Hold	5,000	–	–	0.11%	289
2013 Q3	$461K	Hold	5,000	–	–	0.1%	303
2013 Q2	$423K	Buy	+5,000	New	+$416K	0.1%	311

Other funds holding TMO

JSC

J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's TMO Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 6,000 shares — an estimated $2.91M sold.

NJ State Employees Deferred Compensation Plan first reported a position in TMO in Q2 2013 and held it in 50 quarters. The position peaked at $4M in Q4 2021. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 6,000 Thermo Fisher Scientific shares in Q4 2025, an estimated $2.91M.
NJ State Employees Deferred Compensation Plan first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 50 quarters.
NJ State Employees Deferred Compensation Plan's Thermo Fisher Scientific position peaked at $4M in Q4 2021.
2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.